Centro de Imagem Diagnósticos S.A (AALR3) - Net Assets
Based on the latest financial reports, Centro de Imagem Diagnósticos S.A (AALR3) has net assets worth R$-252.23 Million BRL (≈ $-49.49 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (R$1.78 Billion ≈ $348.75 Million USD) and total liabilities (R$2.03 Billion ≈ $398.24 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Centro de Imagem Diagnósticos S.A PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | R$-252.23 Million |
| % of Total Assets | -14.19% |
| Annual Growth Rate | N/A |
| 5-Year Change | -120.86% |
| 10-Year Change | -120.81% |
| Growth Volatility | 162.78 |
Centro de Imagem Diagnósticos S.A - Net Assets Trend (2010–2025)
This chart illustrates how Centro de Imagem Diagnósticos S.A's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see AALR3 market cap.
Annual Net Assets for Centro de Imagem Diagnósticos S.A (2010–2025)
The table below shows the annual net assets of Centro de Imagem Diagnósticos S.A from 2010 to 2025. Also explore Centro de Imagem Diagnósticos S.A net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | R$-252.23 Million ≈ $-49.49 Million |
-122.19% |
| 2024-12-31 | R$1.14 Billion ≈ $223.06 Million |
+20.43% |
| 2023-12-31 | R$943.99 Million ≈ $185.23 Million |
-3.86% |
| 2022-12-31 | R$981.92 Million ≈ $192.67 Million |
-18.81% |
| 2021-12-31 | R$1.21 Billion ≈ $237.31 Million |
-1.16% |
| 2020-12-31 | R$1.22 Billion ≈ $240.11 Million |
-7.30% |
| 2019-12-31 | R$1.32 Billion ≈ $259.01 Million |
+1.56% |
| 2018-12-31 | R$1.30 Billion ≈ $255.03 Million |
+2.32% |
| 2017-12-31 | R$1.27 Billion ≈ $249.25 Million |
+4.81% |
| 2016-12-31 | R$1.21 Billion ≈ $237.80 Million |
+65.34% |
| 2015-12-31 | R$733.00 Million ≈ $143.83 Million |
-1.39% |
| 2014-12-31 | R$743.32 Million ≈ $145.85 Million |
+165.96% |
| 2013-12-31 | R$279.49 Million ≈ $54.84 Million |
+18.97% |
| 2012-12-31 | R$234.93 Million ≈ $46.10 Million |
-8.64% |
| 2011-12-31 | R$257.14 Million ≈ $50.46 Million |
+621.00% |
| 2010-12-31 | R$35.66 Million ≈ $7.00 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Centro de Imagem Diagnósticos S.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 200731800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | R$1.12 Billion | % |
| Other Comprehensive Income | R$608.25 Million | % |
| Total Equity | R$-277.54 Million | 100.00% |
Centro de Imagem Diagnósticos S.A Competitors by Market Cap
The table below lists competitors of Centro de Imagem Diagnósticos S.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aesler Grup Internasional Tbk Pt
JK:RONY
|
$107.67 Million |
|
Golf & Co Group Ltd
TA:GOLF
|
$107.72 Million |
|
Net Insight AB (publ)
ST:NETI-B
|
$107.74 Million |
|
UBcare. Co. Ltd
KQ:032620
|
$107.79 Million |
|
Charnic Capital Tbk PT
JK:NICK
|
$107.60 Million |
|
Pulse Seismic Inc
TO:PSD
|
$107.58 Million |
|
MICROPORT CARDIO.MEDTECH.
F:72X
|
$107.57 Million |
|
Supergas Energy Ltd
TA:SPGE
|
$107.57 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Centro de Imagem Diagnósticos S.A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,094,793,000 to -277,542,000, a change of -1,372,335,000 (-125.4%).
- Net loss of 1,372,344,000 reduced equity.
- Dividend payments of 17,227,000 reduced retained earnings.
- New share issuances of 9,000 increased equity.
- Other comprehensive income decreased equity by 511,000,000.
- Other factors increased equity by 528,227,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | R$-1.37 Billion | -494.46% |
| Dividends Paid | R$17.23 Million | -6.21% |
| Share Issuances | R$9.00K | +0.0% |
| Other Comprehensive Income | R$-511.00 Million | -184.12% |
| Other Changes | R$528.23 Million | +190.32% |
| Total Change | R$- | -125.35% |
Book Value vs Market Value Analysis
This analysis compares Centro de Imagem Diagnósticos S.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | R$4.78 | R$3.60 | x |
| 2013-12-31 | R$5.43 | R$3.60 | x |
| 2014-12-31 | R$13.02 | R$3.60 | x |
| 2015-12-31 | R$7.79 | R$3.60 | x |
| 2016-12-31 | R$11.60 | R$3.60 | x |
| 2017-12-31 | R$10.41 | R$3.60 | x |
| 2018-12-31 | R$10.60 | R$3.60 | x |
| 2019-12-31 | R$10.87 | R$3.60 | x |
| 2020-12-31 | R$10.09 | R$3.60 | x |
| 2021-12-31 | R$10.00 | R$3.60 | x |
| 2022-12-31 | R$8.06 | R$3.60 | x |
| 2023-12-31 | R$7.76 | R$3.60 | x |
| 2024-12-31 | R$9.21 | R$3.60 | x |
| 2025-12-31 | R$-1.82 | R$3.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Centro de Imagem Diagnósticos S.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -118.94%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-2.93%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 12.27% | 15.48% | 0.56x | 1.41x | R$5.28 Million |
| 2013 | 10.15% | 10.03% | 0.47x | 2.16x | R$410.90K |
| 2014 | -0.57% | -1.06% | 0.27x | 1.99x | R$-77.74 Million |
| 2015 | -1.78% | -1.82% | 0.46x | 2.15x | R$-84.37 Million |
| 2016 | 1.26% | 1.55% | 0.44x | 1.85x | R$-102.57 Million |
| 2017 | 0.55% | 0.62% | 0.47x | 1.87x | R$-115.29 Million |
| 2018 | 3.19% | 3.72% | 0.49x | 1.76x | R$-85.61 Million |
| 2019 | 3.22% | 3.85% | 0.45x | 1.87x | R$-86.92 Million |
| 2020 | -8.18% | -10.49% | 0.37x | 2.13x | R$-216.47 Million |
| 2021 | -0.48% | -0.49% | 0.45x | 2.16x | R$-123.15 Million |
| 2022 | -23.99% | -21.00% | 0.41x | 2.75x | R$-322.78 Million |
| 2023 | -24.84% | -19.32% | 0.44x | 2.91x | R$-319.62 Million |
| 2024 | -11.79% | -10.61% | 0.42x | 2.64x | R$-238.60 Million |
| 2025 | 0.00% | -118.94% | 0.65x | 0.00x | R$-1.34 Billion |
Industry Comparison
This section compares Centro de Imagem Diagnósticos S.A's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $124,694,000
- Average return on equity (ROE) among peers: 13.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Centro de Imagem Diagnósticos S.A (AALR3) | R$-252.23 Million | 12.27% | N/A | $107.60 Million |
| Diagnósticos da América S.A (DASA3) | $97.55 Million | 0.00% | 0.62x | $696.45 Million |
| Fleury S.A. (FLRY3) | $151.84 Million | 27.64% | 3.06x | $2.28 Billion |
About Centro de Imagem Diagnósticos S.A
Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood cou… Read more